Literature DB >> 17928188

Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.

A Sasaki1, F Tanaka, K Mimori, H Inoue, S Kai, K Shibata, M Ohta, S Kitano, M Mori.   

Abstract

AIMS: CD4+ CD25+ forkhead box P3 (FOXP3)+ T(reg) accumulate in malignant tumors and negatively regulate anti-tumor immunity. To determine the prognostic value of tumor-infiltrating regulatory T cells (T(reg)), we conducted a retrospective study on 164 patients with hepatocellular carcinoma (HCC) who underwent curative hepatic resection.
METHODS: We investigated the number of tumor-infiltrating FOXP3+ T(reg) in formalin-fixed HCC specimens. The number of FOXP3+ T(reg) for each case was calculated as the total number of positive cells per 10 high-power fields (HPF) on light microscopy. Long-term survival rate after resection according to the number of FOXP3+ T(reg) was accessed by univariate and multivariate analyses.
RESULTS: The mean and median numbers of tumor-infiltrating T(reg) were 29.0 and 14 per 10 HPF for FOXP3+ T(reg). The number of FOXP3+ T(reg) was positively correlated with preoperative serum alpha-fetoprotein levels. The disease-free survival rate was significantly lower in patients with high T(reg) counts (> or =14, n=84) than in those with low T(reg) counts (<14, n=80) (13.6% vs. 25.7% at 5 years; P=0.02). By multivariate analysis, the high T(reg) counts, presence of portal vein invasion, and elevation of preoperative aspartate aminotransferase level were independent predictive factors of tumor recurrence.
CONCLUSIONS: The high number of tumor-infiltrating T(reg) is an independent predictive factor of tumor recurrence after hepatic resection for HCC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17928188     DOI: 10.1016/j.ejso.2007.08.008

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  33 in total

1.  T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases.

Authors:  Steven C Katz; Charan Donkor; Kristen Glasgow; Venu G Pillarisetty; Mithat Gönen; N Joseph Espat; David S Klimstra; Michael I D'Angelica; Peter J Allen; William Jarnagin; Ronald P Dematteo; Murray F Brennan; Laura H Tang
Journal:  HPB (Oxford)       Date:  2010-12       Impact factor: 3.647

2.  Expression of CD4(+)CD25(high)CD127(low/-) regulatory T cells in transitional cell carcinoma patients and its significance.

Authors:  Xi Zhu; Lin-Lin Ma; Tian Ye
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 3.  Prognostic significance of regulatory T lymphocytes in patients with hepatocellular carcinoma.

Authors:  Ai-Bin Zhang; Yi-Gang Qian; Shu-Sen Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2016 Dec.       Impact factor: 3.066

4.  A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix.

Authors:  Walayat Shah; Xiaofei Yan; Li Jing; Yi Zhou; Hongwei Chen; Yili Wang
Journal:  Cell Mol Immunol       Date:  2010-11-22       Impact factor: 11.530

5.  Tumor secretion of VEGF induces endothelial cells to suppress T cell functions through the production of PGE2.

Authors:  Jennifer K Mulligan; Steven A Rosenzweig; M Rita I Young
Journal:  J Immunother       Date:  2010 Feb-Mar       Impact factor: 4.456

6.  Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.

Authors:  W K Yip; M A Abdullah; S M Yusoff; H F Seow
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

7.  Changes of CD4(+) CD25 (+) regulatory T cells in peripheral blood in patients with hepatocellular carcinoma before and after TACE.

Authors:  Bin Xiong; Gansheng Feng; Shihua Luo; Huimin Liang; Lingyun Qiu; Chuansheng Zheng; Xi Liu; Guofeng Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

8.  Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients.

Authors:  Paulette Mhawech-Fauceglia; Dan Wang; Liaquat Ali; Shashikant Lele; Michael A Huba; Song Liu; Kunle Odunsi
Journal:  Cancer Immun       Date:  2013-01-15

9.  Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions.

Authors:  Jennifer K Mulligan; Terry A Day; M Boyd Gillespie; Steven A Rosenzweig; M Rita I Young
Journal:  Hum Immunol       Date:  2009-02-12       Impact factor: 2.850

10.  Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.

Authors:  Yi-Lan Zhang; Jiang Li; Hao-Yuan Mo; Fang Qiu; Li-Min Zheng; Chao-Nan Qian; Yi-Xin Zeng
Journal:  Mol Cancer       Date:  2010-01-10       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.